(Q54074277)

24 May 2018

title

A new treatment for endometrial cancer with gonadotrophin releasing-hormone analogue (English)

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

15 November 2022

1 reference

Hope-Stone HF

8

1 reference

24 May 2018

C. J. Gallagher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751436

15 November 2022

R. T. Oliver

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751436

15 November 2022

D. H. Oram

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751436

15 November 2022

C. G. Fowler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751436

15 November 2022

P. R. Blake

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751436

15 November 2022

B. S. Mantell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751436

15 November 2022

M. L. Slevin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751436

15 November 2022

H. F. Hope-Stone

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751436

15 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1751436

15 November 2022

publication date

1 October 1991

1 reference

24 May 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1471-0528.1991.tb15343.x

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-0528.1991.tb15343.x/fullpdf

15 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

British Journal of Obstetrics and Gynaecology

15 November 2022

published in

1 reference

24 May 2018

volume

98

1 reference

24 May 2018

page(s)

1037-1041

1 reference

24 May 2018

issue

10

1 reference

24 May 2018

Doxorubicin-cisplatin-vinblastine combination chemotherapy of advanced endometrial carcinoma: a Southwest Oncology Group Study

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Luteinizing hormone-releasing hormone binds to enriched human placental membranes and stimulates in vitro the synthesis of bioactive human chorionic gonadotropin

15 November 2022

2

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Clinical stage I and II endometrial carcinoma treated with surgery and/or radiation therapy: analysis of prognostic and treatment-related factors

15 November 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

15 November 2022

Confidence intervals

4

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation).

15 November 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

15 November 2022

6

27

687

Cao Yongqing

1984

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

CA 125: a useful marker in endometrial carcinoma

15 November 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

15 November 2022

Cancer Treatment Reports

8

70

1019

Edmonson K. H.

1986

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Zoladex: endocrine and therapeutic effects in post-menopausal breast cancer

15 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Medical castration produced by the GnRH analogue leuprolide to treat metastatic breast cancer

15 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Extrapituitary Actions of Gonadotropin-Releasing Hormone*

15 November 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Leuprolide acetate in the treatment of refractory or persistent epithelial ovarian cancer

15 November 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

426 cases of stage I endometrial carcinoma: a clinicopathological analysis

15 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Synthesis of the porcine LH- and FSH-releasing hormone by the solid-phase method.

15 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist

15 November 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

CA19-9, CA125 and CEA in endometrial carcinoma tissue and its relation to hormone receptor content and histological grading

15 November 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer.

15 November 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Steroid hormones modulate the release of immunoreactive gonadotropin-releasing hormone from cultured human placental cells

15 November 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic endometrial carcinoma

15 November 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Specific binding of luteinizing hormone releasing hormone to human luteal tissue

15 November 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Buserelin as primary therapy in advanced prostatic carcinoma

15 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Pituitary and gonadal desensitization after continuous luteinizing hormone-releasing hormone infusion in normal females.

15 November 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

The treatment of advanced endometrial cancer with hydroxyprogesterone caproate

15 November 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

The Presence of Gonadotropin Receptors in Nonpregnant Human Uterus, Human Placenta, Fetal Membranes, and Decidua*

15 November 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube. I. Immunohistochemical detection

15 November 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Clinical effects of gonadotropin-releasing hormone analogue in metastatic carcinoma of prostate

15 November 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

Treatment of Advanced Endometrial Carcinoma with Tamoxifen

15 November 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1471-0528.1991.TB15343.X

15 November 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1751436

15 November 2022

1 reference

24 May 2018